Oxford BioMedica PLC (OXBDF)

[marcusl2]

Vulpes buy

Today : Wednesday 11 April 2018

TIDMOXB
RNS Number : 6083K
Oxford Biomedica PLC
11 April 2018
Director Dealings / Market Share Purchase
Oxford, UK - 11 April 2018: Oxford BioMedica plc ("Oxford BioMedica" or "the Group") (LSE: OXB), a leading gene and cell therapy group, today announces that Vulpes Testudo Fund, a person closely associated with Martin Diggle, Non-Executive Director, has purchased 1,000,000 ordinary shares of 1p each ("Ordinary Shares") in the Company on 10 April 2018 on the London Stock Exchange at a price of 11.0p per share. Following this purchase Vulpes Testudo/Vulpes Life Sciences Fund holds 582,008,434 ordinary shares representing 17.7% of the Company.